Ever found yourself at the store, reaching for the most convenient bottle of over-the-counter eyedrops, assuming whip-smart regulators have given it a clean, green tick? Well, a rising tide of recalls has thrown a damp cloth on this assumption. It seems our officials are under-armed, facing a game of hide-and-seek with global manufacturing plants playing on the home field advantage.
The knight in shining armour — The Food and Drug Administration (FDA) — is ringing the alarm and calling on Congress to reinforce their arsenal. Mandatory drug recalls and conditional shipments subject to prior inspection from eyedrop manufacturers are just a couple of the notches they aim to add onto their belt of power.
